Simplex Trading, LLC Theravance Biopharma, Inc. Transaction History

Simplex Trading, LLC

$3.28 Billion
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$7.66 - $10.25 $84 - $112	-11 Reduced 3.29%	323 $2,000
Q2 2024 Jul 25, 2024	BUY	$8.29 - $9.92 $2,768 - $3,313	334 New	334 $2,000
Q3 2022 Nov 04, 2022	BUY	$8.39 - $10.22 $374,840 - $456,598	44,677 Added 1308.26%	48,092 $487,000
Q2 2022 Aug 03, 2022	SELL	$8.41 - $10.34 $41,932 - $51,555	-4,986 Reduced 59.35%	3,415 $30,000
Q1 2022 May 02, 2022	SELL	$8.33 - $12.96 $122,151 - $190,045	-14,664 Reduced 63.58%	8,401 $80,000
Q4 2021 Feb 23, 2022	BUY	$7.42 - $11.05 $164,835 - $245,475	22,215 Added 2613.53%	23,065 $254,000
Q3 2021 Oct 28, 2021	BUY	$6.77 - $14.41 $677 - $1,441	100 Added 13.33%	850 $12,000
Q2 2021 Aug 12, 2021	BUY	$14.52 - $22.46 $10,890 - $16,845	750 New	750 $10,000
Q1 2021 Apr 26, 2021	SELL	$16.57 - $21.08 $248 - $316	-15 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$14.89 - $20.16 $223 - $302	15 New	15 $0
Q3 2020 Oct 14, 2020	SELL	$14.79 - $22.49 $16,313 - $24,806	-1,103 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$20.64 - $30.69 $22,765 - $33,851	1,103 New	1,103 $23,000
Q1 2020 Apr 29, 2020	SELL	$17.84 - $31.21 $119,331 - $208,763	-6,689 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$16.12 - $25.89 $26,533 - $42,614	1,646 Added 32.64%	6,689 $173,000
Q3 2019 Oct 15, 2019	BUY	$16.51 - $23.78 $19,349 - $27,870	1,172 Added 30.28%	5,043 $98,000
Q2 2019 Jul 26, 2019	BUY	$15.6 - $25.15 $60,294 - $97,204	3,865 Added 64416.67%	3,871 $63,000
Q1 2019 Apr 18, 2019	SELL	$22.57 - $28.15 $3,408 - $4,250	-151 Reduced 96.18%	6 $0
Q4 2018 Jan 16, 2019	BUY	$22.52 - $35.07 $2,702 - $4,208	120 Added 324.32%	157 $4,000
Q3 2018 Oct 23, 2018	SELL	$22.83 - $32.67 $15,341 - $21,954	-672 Reduced 94.78%	37 $1,000
Q2 2018 Jul 30, 2018	BUY	$22.06 - $25.52 $14,934 - $17,277	677 Added 2115.63%	709 $16,000
Q1 2018 Apr 26, 2018	BUY	$23.37 - $29.71 $747 - $950	32 New	32 $0
Q4 2017 Jan 10, 2018	SELL	$25.82 - $35.66 $30,390 - $41,971	-1,177 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$23.88 - $34.96 $28,106 - $41,147	1,177	1,177 $40,000

Others Institutions Holding TBPH

# of Institutions

129

Shares Held

46.5M

Call Options Held

600

Put Options Held

300

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$88.9 Million
14.29% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$69.7 Million
2.02% of portfolio
Newtyn Management, LLC New York, NY

4.76M
Shares

$44.5 Million
9.1% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$35.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$25.8 Million
2.79% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $624M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account